| 000 | 01093 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515023452.0 | ||
| 264 | 0 | _c20060803 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1517/14656566.7.7.849 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSkipper, Lisa | |
| 245 | 0 | 0 |
_aPolymorphisms in candidate genes: implications for the current treatment of Parkinson's disease. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cMay 2006 |
||
| 300 |
_a849-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aGenetic Variation _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 700 | 1 | _aLiu, Jian-Jun | |
| 700 | 1 | _aTan, Eng-King | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 7 _gno. 7 _gp. 849-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.7.7.849 _zAvailable from publisher's website |
| 999 |
_c16238319 _d16238319 |
||